Results 41 to 50 of about 940 (132)
Revista do Instituto de Medicina Tropical de São Paulo, 1991 É proposto processo para a triagem da capacidade terapêutica de medicamentos na infecção experimental pelo Trypanosoma cruzi. O método tem base no emprego de triatomíneos parasitados que se alimentam, decorridos períodos diferentes para haver ...
Rubens Campos +3 more
doaj +1 more source
Prevalencia de anticuerpos IgG contra Trypanosoma cruzi en habitantes mayores de 14 años de la aldea "Pie de la Cuesta" del municipio de San Pedro Pinula, Jalapa. [PDF]
, 2014 La enfermedad de Chagas está relacionada con los problemas socioeconómicos propios de los países subdesarrollados, tales como pobreza extrema y falta de educación, características que se observan con mucha frecuencia en el área suburbana y rural
Santisteban Ruiz, Geidy Azmavett
core
PARA UMA DOENÇA TÃO ANTIGA, O VISLUMBRE DE NOVOS TRATAMENTOS PROMISSORES NA DOENÇA DE CHAGAS [PDF]
, 2021 It has been more than 100 years since the discovery of Chagas Disease (CD). However, the repertoire indicated for its treatment is still limited. Thus, this article aims to present a review of the new pharmacological strategies being studied for CD. This
Hilgert, Sabrina Sehn +3 more
core +1 more source
Ethiological treatment of acute and chronic Chagas' heart disease
São Paulo Medical JournalThe uncertaintties in the ethiological treatment of Chagas' Disease are consequence of the lack of entire knowledge of its pathogeny and the no existence of a healing criterium.
Abílio Augusto Fragata Filho +2 more
doaj +1 more source
Revista do Instituto de Medicina Tropical de São Paulo, 1988 Os níveis de anticorpos líticos foram determinados em pacientes chagásicos crônicos, tratados com nifurtimox ou benzonidazol, através da Lise Mediada por Complemento (LMCo).
Antonio Marcos de Aparecida Levy +2 more
doaj +1 more source
Revista do Instituto de Medicina Tropical de São Paulo, 1997 Strains of Trypanosoma cruzi from different geographical areas have shown different levels of susceptibility to trypanocidal drugs. The susceptibility in vivo to benznidazole was investigated in eighteen strains of T. cruzi.
Max Jean de Ornelas TOLEDO +6 more
doaj +1 more source
[Peripheral polyneuropathy induced by benzonidazole in the treatment of Chagas' disease].
Arquivos de neuro-psiquiatria, 1987 Neurophysiological examination before and after the administration of benzonidazole, has shown peripheral polyneuropathy induced by this drug in most of the patients treated for chronic Chagas' disease. The polyneuropathy was mostly axonal and it was dose dependent being more severe in patients who had denervation of skeletal muscles before receiving ...
C R, Defaria +2 more
openaire +1 more source
Development of effervescent tablets containing benznidazole complexed with cyclodextrin
Journal of Pharmacy and Pharmacology, 2011 Abstract Objectives Benznidazole (BNZ), the primary chemotherapy agent used to treat Chagas disease, has poor aqueous solubility, which results in low bioavailability. The purpose of this work was to develop stable effervescent tablets using an inclusion complex of BNZ with cyclodextrin (CD).
Flávia Pires, Maximiano +4 more
openaire +2 more sources
Detecção de DNA de Leishmania spp. no sangue e em esperma de indivíduos residentes na região Amazônica [PDF]
, 2014 Dissertação (mestrado)—Universidade de Brasília, Faculdade de Medicina, Pós-Graduação em Ciências Médicas, Laboratório Multidisciplinar de Pesquisa em Doença de Chagas, 2014A leishmaniose é uma zoonose transmitida por flebotomíneos e causada por várias ...
Vital, Tamires Emanuele
core
Paniculite chagásica pós-transplante renal: relato de caso
Brazilian Journal of Nephrology, 2016 Resumo A doença de Chagas acarreta grande morbimortalidade, por parasitemia aguda ou por lesões cardíacas, digestivas, cutâneas ou neurológicas crônicas. Os países latino-americanos apresentam a maioria das pessoas infectadas ou em risco.
Fábio Prestes de Campos +7 more
doaj +1 more source